Solid forms of tofacitinib salts

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9260438
SERIAL NO

14616001

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Solid and crystalline forms of tofacitinib hydrochloride and tofacitinib hydrobromide, processes for the preparation thereof and processes for the use thereof in preparing tofacitinib citrate are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
APOTEX INCTORONTO ONTARIO M9L 1T9

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bodhuri, Prabhudas Brantford, CA 19 41
Cammisa, Eduardo Gustavo Markham, CA 7 1
Green, Stuart P Mount Pleasant, CA 8 2
Karadeolian, Avedis Cambridge, CA 17 4
McPhail, Cameron L Brantford, CA 9 30
Wang, Fan Burlington, CA 436 2764

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 16, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00